DISCOVER YOUR NEUROGENETIC ENDOWMENT AND HOW IT AFFECTS YOUR INVESTMENT DECISIONS.
Emerging from the new discipline of genoeconomics, developed at Cornell University by Professor Daniel Benjamin, nextSignals is pioneering personalized methods for improving investment-related decision making and constructing personalized portfolios using genetic data. (1,2)
5-HTTLPR LL ALLELE CARRIER
“Long and strong,” I would say, as I held onto losing positions! I’ve learned that a genetic variation underpinning my natural optimism also reduces my penchant for processing negative market information.
Understanding how genes that regulated my serotonin levels contributed to an irrationally bullish bias helped me assume a more agnostic view of market events.
DRD4P SHORT ALLELE CARRIER
When making investment decisions, I often rely on “…one good reason.” Then I balance risk-return trade-offs and execute trading rules. I exercise discretion. I am not impulsive.
My neurogenetic analysis shed light on how my genes might be my “edge!” With healthy levels of dopamine, my investment process essentially amounts to supervising my algorithm.
TPH1 VARIANT CARRIER
I over-traded and overestimated my investing abilities. My interest in following daily fluctuations reduced both my portfolio performance and, frankly, my enjoyment of life.
Understanding my neurogenetics made one thing very clear: I needed to think slower. After I learned a few emotion regulation strategies, my average gains exceeded my average losses.
HTR1A G ALLELE HOMOZYGOTE
Volatility and I have never gotten along. A couple of consecutive downside days and I’m not sleeping. Apparently, my fear of portfolio losses is hard-wired into me.
Understanding how my genetics affects my loss aversion has allowed me to invest without being at the whim of my emotions. I’m sleeping much better now!